Pharmafile Logo

#RemoteDetailing

- PMLiVE

Snapchat arrives at scientific meetings

And NICE becomes the first public health body to use the platform

- PMLiVE

Novartis gets lung cancer OK for Tafinlar/Mekinist combo

It can now be used to treat BRAF V600E-positive NSCLC patients in Europe

Verona Pharma strengthens senior management team

Richard Hennings joins as commercial director

- PMLiVE

Pfizer keeps nose ahead of rivals with new Ibrance approval

FDA licenses new indication for the breast cancer treatment

The Medicines Company strengthens board of directors

Paris Panayiotopoulos joins from ARIAD Pharmaceuticals

- PMLiVE

Connecting the dots

What happens ‘here’ impacts what happens ‘there’

- PMLiVE

Danish Medicines Agency urges caution on health app use

Says mobile applications on their own cannot make a diagnosis

- PMLiVE

Behaviour change needs a quantified approach

How pharmaceutical brands can use behaviour change to communicate their treatments to patients

- PMLiVE

Walmsley steps up to chief executive role at GSK

The firm's first female CEO, she takes over from Sir Andrew Witty

Novartis day

Novartis files CAR-T therapy in US, with swift review

CTL109 candidate gets FDA priority review status

- PMLiVE

Revolution Medicines appoints Dr Stephen Kelsey

He joins the firm from Onkaido Therapeutics

- PMLiVE

Kate Paxton to lead Ketchum’s UK healthcare practice

Agency also picks Neil McLelland for a leadership role at Inspired Science

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links